LKMNH Fair Value & Analysis
Healthcare · TR · Market cap 2.9B TRY
Fair value as of: Aug 13, 2026
From 16 valuation models · updated today
Share price −5.6% over the past month.
Below-average quality, screening 14% undervalued on our models.
What matters now
- Our model range runs from 11.48 TRY (bear) to 19.14 TRY (bull), base 15.31 TRY. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 28/100 (below-average quality) with medium evidence: read the verdict with care.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 1.30 TRY – 20.99 TRY · fair‑value band 11.48 TRY – 19.14 TRY · the 13.45 TRY price screens below the 15.31 TRY fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
LKMNH (LKMNH) currently trades at 13.45 TRY, while our model-based Fair Value estimate is 15.31 TRY, implying the stock looks roughly 13.8% undervalued today. The Quality Score stands at 28/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, LKMNH generated revenue of 4.4B TRY at a net margin of 3.2%. Revenue grew 37.8% year over year. It earns a return on equity of 5.2%. Net debt stands at 2.2B TRY. Fundamentals as of Aug 13, 2026
Our scenario range runs from 11.48 TRY (bear case) to 19.14 TRY (bull case); at 13.45 TRY, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 37% below its 52-week high and 2% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -12% fair-value upside, at 14%, LKMNH screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 16 models by family
Widest divergence: Growth Earnings (32.34 TRY) versus Asset-Based (7.34 TRY). Highest evidence: Residual Income (76).
Notify me when LKMNH reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 30 · Market factors (momentum, volatility) 35
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Lokman Hekim Engürüsag Saglik, Turizm, Egitim Hizmetleri ve Insaat Taahhüt A.S., together with its subsidiaries, operates hospitals, medical centers, laboratories, and medical units in Turkey. The company offers health care; e-health; imaging and diagnostic; and logistics and support services.
Full company description
Lokman Hekim Engürüsag Saglik, Turizm, Egitim Hizmetleri ve Insaat Taahhüt A.S., together with its subsidiaries, operates hospitals, medical centers, laboratories, and medical units in Turkey. The company offers health care; e-health; imaging and diagnostic; and logistics and support services. It is also involved in the insurance and brokerage; construction and tourism; production of milk; raising of livestock; sale of feeds; and hospital rental businesses. Lokman Hekim Engürüsag Saglik, Turizm, Egitim Hizmetleri ve Insaat Taahhüt A.S. was incorporated in 1996 and is based in Ankara, Turkey.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
LKMNH reported revenue of 4.2B TRY in FY2025 versus 453M TRY in FY2021, a compound +74.8%/yr. Reported net income was 150M TRY in FY2025, compounding +21.0%/yr from FY2021.
Watch LKMNH: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 263 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.58 SGD | 1.44 SGD | -44% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$36.01 | R$47.31 | +31% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
| Max Healthcare Institute Limited MAXHEALTH | ₹1,103 | ₹284.87 | -74% |
Compare LKMNH with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is LKMNH overvalued or undervalued?
What is the fair value of LKMNH?
What is the quality score of LKMNH?
What is the revenue of LKMNH?
What is the net profit margin of LKMNH?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track LKMNH and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.